Vaccin contre les méningocoques de type ACWY (enfant de moins de 2 ans) :

This tender, originating from France and published on the TED (Tenders Electronic Daily) platform, seeks the procurement of Meningococcal ACWY conjugate vaccine for infants under two years of age. The contracting authority, managed by the Publications Office of the European Union, is looking to secure a reliable supply of this critical public health product.

The requirement is for a vaccine specifically targeting serogroups A, C, W, and Y of *Neisseria meningitidis*, a bacterium that can cause serious and potentially life-threatening infections such as meningitis and sepsis. The vaccine is intended for administration to very young children, a demographic particularly vulnerable to these diseases.

Typical requirements for such a tender would include the provision of a vaccine that meets stringent European Medicines Agency (EMA) or equivalent regulatory approval standards. Bidders will likely be expected to demonstrate robust manufacturing capabilities, adherence to Good Manufacturing Practices (GMP), and a proven track record in vaccine supply chain management. Furthermore, evidence of product efficacy and safety data, along with comprehensive packaging, labeling, and cold chain logistics capabilities, will be essential. The tender will likely specify delivery timelines, quantities, and potential for ongoing supply agreements. Successful bidders will need to offer a product that aligns with national immunization program guidelines and contributes to the prevention of meningococcal disease in infants.